NGM Biopharmaceuticals, Inc. Debt to Equity Ratio 2018-2023 | NGM
Current and historical debt to equity ratio values for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NGM Biopharmaceuticals, Inc. debt/equity for the three months ending December 31, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-12-31 |
$0.02B |
$0.15B |
0.14 |
2023-09-30 |
$0.02B |
$0.17B |
0.13 |
2023-06-30 |
$0.03B |
$0.19B |
0.15 |
2023-03-31 |
$0.04B |
$0.22B |
0.17 |
2022-12-31 |
$0.05B |
$0.26B |
0.18 |
2022-09-30 |
$0.05B |
$0.29B |
0.18 |
2022-06-30 |
$0.05B |
$0.29B |
0.16 |
2022-03-31 |
$0.05B |
$0.31B |
0.16 |
2021-12-31 |
$0.07B |
$0.34B |
0.20 |
2021-09-30 |
$0.06B |
$0.35B |
0.18 |
2021-06-30 |
$0.05B |
$0.37B |
0.13 |
2021-03-31 |
$0.05B |
$0.40B |
0.12 |
2020-12-31 |
$0.05B |
$0.28B |
0.18 |
2020-09-30 |
$0.05B |
$0.28B |
0.18 |
2020-06-30 |
$0.05B |
$0.30B |
0.15 |
2020-03-31 |
$0.04B |
$0.32B |
0.13 |
2019-12-31 |
$0.05B |
$0.33B |
0.15 |
2019-09-30 |
$0.05B |
$0.34B |
0.15 |
2019-06-30 |
$0.05B |
$0.35B |
0.15 |
2019-03-31 |
$0.35B |
$-0.12B |
-2.94 |
2018-12-31 |
$0.35B |
$-0.11B |
-3.27 |
2018-09-30 |
$0.00B |
$0.00B |
0.00 |
2018-06-30 |
$0.00B |
$0.00B |
0.00 |
2018-03-31 |
$0.00B |
$0.00B |
0.00 |
2017-12-31 |
$0.00B |
$0.00B |
0.00 |